Literature DB >> 9588624

Coupling of D1 and D5 dopamine receptors to multiple G proteins: Implications for understanding the diversity in receptor-G protein coupling.

A Sidhu1.   

Abstract

Dopamine receptors are a subclass of the super family of G protein-coupled receptors, that transduce their effects by coupling to specific G proteins. Within the dopamine receptor family, the adenylyl cyclase stimulatory receptors include the D1 and D5 subtypes. The D1 and D5 dopamine receptors are genetically distinct, sharing >80% sequence homology within the highly conserved seven transmembrane spanning domains, but displaying only 50% overall homology at the amino acid level. When expressed in transfected GH4C1 rat pituitary cells, both D1 and D5 receptors stimulate adenylyl cyclase and have identical affinities toward dopaminergic agonists and antagonists. In order to analyze specific signaling pathways mediated by activation of either D1 or D5 receptors, we have identified the G proteins that are coupled to these receptors. Through functional analyses and competition binding studies, and from immunoprecipitation techniques, using antisera against the various alpha subunits of G proteins, we have established that both D1 and D5 receptors couple to G(s)alpha. In addition, D1 receptors are also coupled to G(o)alpha. Since G(o)alpha has been implicated in the regulation of Ca2+, K+, and Na+ channels, this finding would suggest that D1 receptors can mediate the functional activity of these ion channels. There is also evidence to indicate that D5 receptors couple to G(z)alpha, a novel G protein abundantly expressed in neurons. Thus, despite similar pharmacological properties, such differential coupling of D1 and D5 receptors to G proteins other than G(s)alpha, indicates that dopamine can transduce varied signaling responses upon the simultaneous stimulation of both these receptors.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9588624     DOI: 10.1007/BF02740640

Source DB:  PubMed          Journal:  Mol Neurobiol        ISSN: 0893-7648            Impact factor:   5.590


  51 in total

Review 1.  G proteins.

Authors:  J R Hepler; A G Gilman
Journal:  Trends Biochem Sci       Date:  1992-10       Impact factor: 13.807

2.  Cloning of the gene for a human dopamine D5 receptor with higher affinity for dopamine than D1.

Authors:  R K Sunahara; H C Guan; B F O'Dowd; P Seeman; L G Laurier; G Ng; S R George; J Torchia; H H Van Tol; H B Niznik
Journal:  Nature       Date:  1991-04-18       Impact factor: 49.962

Review 3.  Structures of dopamine receptors.

Authors:  B F O'Dowd
Journal:  J Neurochem       Date:  1993-03       Impact factor: 5.372

4.  Chimeric muscarinic cholinergic: beta-adrenergic receptors that activate Gs in response to muscarinic agonists.

Authors:  S K Wong; E M Parker; E M Ross
Journal:  J Biol Chem       Date:  1990-04-15       Impact factor: 5.157

5.  mu-Opioid receptors inhibit dopamine-stimulated activity of type V adenylyl cyclase but enhance dopamine-stimulated activity of type VII adenylyl cyclase.

Authors:  M Yoshimura; H Ikeda; B Tabakoff
Journal:  Mol Pharmacol       Date:  1996-07       Impact factor: 4.436

6.  Cell-specific expression and function of adenylyl cyclases in rat pituitary tumour cell lines.

Authors:  R H Paulssen; P W Johansen; J O Gordeladze; O Nymoen; E J Paulssen; K M Gautvik
Journal:  Eur J Biochem       Date:  1994-05-15

7.  A C-terminally truncated human parathyroid hormone receptor is functional and activates multiple G proteins.

Authors:  H Schneider; J H Feyen; K Seuwen
Journal:  FEBS Lett       Date:  1994-09-05       Impact factor: 4.124

8.  Dopaminergic inhibition of catecholamine secretion from chromaffin cells: evidence that inhibition is mediated by D4 and D5 dopamine receptors.

Authors:  M K Dahmer; S E Senogles
Journal:  J Neurochem       Date:  1996-01       Impact factor: 5.372

9.  Gz-mediated hormonal inhibition of cyclic AMP accumulation.

Authors:  Y H Wong; B R Conklin; H R Bourne
Journal:  Science       Date:  1992-01-17       Impact factor: 47.728

10.  Characterization of subtype-specific antibodies to the human D5 dopamine receptor: studies in primate brain and transfected mammalian cells.

Authors:  C Bergson; L Mrzljak; M S Lidow; P S Goldman-Rakic; R Levenson
Journal:  Proc Natl Acad Sci U S A       Date:  1995-04-11       Impact factor: 11.205

View more
  7 in total

Review 1.  Dopamine D2 autoreceptor interactome: Targeting the receptor complex as a strategy for treatment of substance use disorder.

Authors:  Rong Chen; Mark J Ferris; Shiyu Wang
Journal:  Pharmacol Ther       Date:  2020-05-27       Impact factor: 12.310

2.  Identification of C10 nitrogen-containing aporphines with dopamine D1 versus D5 receptor selectivity.

Authors:  Anupam Karki; Reecan Juarez; Hari K Namballa; Ian Alberts; Wayne W Harding
Journal:  Bioorg Med Chem Lett       Date:  2020-02-20       Impact factor: 2.823

3.  A Critical Role for Dopamine D5 Receptors in Pain Chronicity in Male Mice.

Authors:  Salim Megat; Stephanie Shiers; Jamie K Moy; Paulino Barragan-Iglesias; Grishma Pradhan; Rebecca P Seal; Gregory Dussor; Theodore J Price
Journal:  J Neurosci       Date:  2017-11-22       Impact factor: 6.167

Review 4.  Role of dopamine receptors in ADHD: a systematic meta-analysis.

Authors:  Jing Wu; Haifan Xiao; Hongjuan Sun; Li Zou; Ling-Qiang Zhu
Journal:  Mol Neurobiol       Date:  2012-05-19       Impact factor: 5.590

5.  D5 (not D1) dopamine receptors potentiate burst-firing in neurons of the subthalamic nucleus by modulating an L-type calcium conductance.

Authors:  Jérôme Baufreton; Maurice Garret; Alicia Rivera; Adélaïda de la Calle; François Gonon; Bernard Dufy; Bernard Bioulac; Anne Taupignon
Journal:  J Neurosci       Date:  2003-02-01       Impact factor: 6.167

Review 6.  Dysregulation of brain dopamine systems in major depressive disorder.

Authors:  Nella C Delva; Gregg D Stanwood
Journal:  Exp Biol Med (Maywood)       Date:  2021-02-16

7.  Dopamine D1/D5 Receptor Signaling Is Involved in Arrhythmogenesis in the Setting of Takotsubo Cardiomyopathy.

Authors:  Mengying Huang; Zhen Yang; Yingrui Li; Huan Lan; Lukas Cyganek; Goekhan Yuecel; Siegfried Lang; Karen Bieback; Ibrahim El-Battrawy; Xiaobo Zhou; Martin Borggrefe; Ibrahim Akin
Journal:  Front Cardiovasc Med       Date:  2022-02-04
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.